Literature DB >> 15172921

Diabetes translation research: where are we and where do we want to be?

K M Venkat Narayan1, Evan Benjamin, Edward W Gregg, Susan L Norris, Michael M Engelgau.   

Abstract

Translation research transforms currently available knowledge into useful measures for everyday clinical and public health practice. We review the progress in diabetes translation research and identify future challenges and opportunities in this field. Several promising interventions to optimize implementation of efficacious diabetes treatments are available. Many of these interventions, singly or in combination, need to be more formally tested in larger randomized or quasi-experimental practical trials using outcomes of special interest to patients (for example, patient satisfaction and quality of life) and policymakers (for example, cost and cost-effectiveness). The long-term outcomes (such as morbidity, mortality, quality of life, and costs) of strategies aimed at improving diabetes care must be assessed. Translation research also needs to incorporate ways of studying complex systems of care. The challenges and opportunities offered by translation research are tremendous.

Entities:  

Mesh:

Year:  2004        PMID: 15172921     DOI: 10.7326/0003-4819-140-11-200406010-00037

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  25 in total

1.  Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients.

Authors:  George L Jackson; David Edelman; Morris Weinberger
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

Review 2.  Primary care practice-based research networks: working at the interface between research and quality improvement.

Authors:  James W Mold; Kevin A Peterson
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

3.  Predictive genetic testing for type 2 diabetes.

Authors:  A Cecile J W Janssens; Marta Gwinn; Rodolfo Valdez; K M Venkat Narayan; Muin J Khoury
Journal:  BMJ       Date:  2006-09-09

4.  How should developing countries manage diabetes?

Authors:  K M Venkat Narayan; Ping Zhang; Desmond Williams; Michael Engelgau; Giuseppina Imperatore; Alka Kanaya; Ambady Ramachandran
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

5.  Measuring organizational readiness for knowledge translation in chronic care.

Authors:  Marie-Pierre Gagnon; Jenni Labarthe; France Légaré; Mathieu Ouimet; Carole A Estabrooks; Geneviève Roch; El Kebir Ghandour; Jeremy Grimshaw
Journal:  Implement Sci       Date:  2011-07-13       Impact factor: 7.327

6.  Lessons from implementing a combined workflow-informatics system for diabetes management.

Authors:  Adrian H Zai; Richard W Grant; Greg Estey; William T Lester; Carl T Andrews; Ronnie Yee; Elizabeth Mort; Henry C Chueh
Journal:  J Am Med Inform Assoc       Date:  2008-04-24       Impact factor: 4.497

Review 7.  Review of electronic decision-support tools for diabetes care: a viable option for low- and middle-income countries?

Authors:  Mohammed K Ali; Seema Shah; Nikhil Tandon
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

8.  Diabetes information technology: designing informatics systems to catalyze change in clinical care.

Authors:  William T Lester; Adrian H Zai; Henry C Chueh; Richard W Grant
Journal:  J Diabetes Sci Technol       Date:  2008-03

9.  Interdisciplinary diabetes care teams operating on the interface between primary and specialty care are associated with improved outcomes of care: findings from the Leuven Diabetes Project.

Authors:  Liesbeth Borgermans; Geert Goderis; Carine Van Den Broeke; Geert Verbeke; An Carbonez; Anna Ivanova; Chantal Mathieu; Bert Aertgeerts; Jan Heyrman; Richard Grol
Journal:  BMC Health Serv Res       Date:  2009-10-07       Impact factor: 2.655

10.  Knowledge of diabetes risk factors and preventive measures among attendees of a primary care center in eastern Saudi Arabia.

Authors:  Abdullah S Aljoudi; Attia Z A Taha
Journal:  Ann Saudi Med       Date:  2009 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.